The present invention is directed towards a process for resolving a
racemic amino compound derived from dihydro-1,3,5-triazines. The
invention is also directed towards the enantiomers of amino derivatives
of dihydro-1,3,5-triazines and to their use for the preparation of
medicaments, in particular for the treatment of diabetes and malaria.